Loading...
•
Dec 31, 2025
Nutex Health Inc Q4 2025 Earnings Report
Nutex Health reported a significant revenue decline in Q4 2025 due to arbitration claim adjustments and timing shifts from prior-year arbitration awards, though patient visits increased.
Key Takeaways
Nutex Health generated $151.7 million in Q4 2025 revenue, down 41.1% year over year primarily due to arbitration claim adjustments and revenue timing differences. Net income attributable to Nutex Health was $11.8 million, and hospital visits increased 6.1% year over year, reflecting higher patient volumes despite revenue volatility.
Q4 revenue declined 41.1% year over year due to arbitration claim true-ups and timing differences in arbitration revenue recognition.
Net income attributable to Nutex Health was $11.8 million in Q4 2025.
Hospital division visits increased 6.1% year over year to 48,205 visits.
Adjusted EBITDA declined significantly year over year due to arbitration-related impacts and accounting adjustments.
Forward Guidance
The company emphasized continued expansion of its micro-hospital network and expects growth driven by new facilities and increased patient volumes.
Positive Outlook
- Strong patient visit growth in the hospital division.
- Expansion strategy through new micro-hospital openings.
- Strong operating cash flow generation in 2025.
- Improved internal controls over financial reporting.
- Strong cash balance supporting growth initiatives.
Challenges Ahead
- Arbitration claim adjustments materially impacted quarterly revenue.
- Revenue recognition timing related to arbitration awards created volatility.
- Adjusted EBITDA declined significantly year over year in Q4.
- Regulatory complexities around arbitration processes remain a risk.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...